Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$165.56
-2.46-1.46%
Last update: Oct 13, 4:00 PM
Glaukos Corp (GKOS) Stock Price, Quote, News & History
GKOSNYSE
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Glaukos (NYSE:GKOS) through any online brokerage.
Other companies in Glaukos’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Glaukos has a consensus price target of $165.75.
The stock price for Glaukos (NYSE: GKOS) is $165.5 last updated October 13, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Glaukos.
Glaukos does not have any upcoming earnings scheduled.
There is no upcoming split for Glaukos.
Glaukos is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
